secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXCELIS TECHNOLOGIES INC (ACLS)
CIK:        0001113232
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001104659-21-133647
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axcelis Q3 revenue $176.7M, record implant systems; EPS $0.81, guides Q4 EPS $0.84
--------------------------------------------------------------------------------

- Revenue $176.7M, up 20% QoQ; system revenue record $126.2M.
- Net income $27.5M ($0.81 diluted EPS) vs $18.9M ($0.55) Q2.
- Gross margin 43.3%, slightly down from 43.5% Q2.
- Q4 outlook: revenue ~$190M, EPS ~$0.84; FY 2021 revenue >$640M.
- Shipped Purion SiC and high-current implanters to Asia/Europe and memory customers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/0001104659-21-133647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/tm2131675d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-133647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer